Fig. 1From: Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilatorMean change in spirometric results; (a) FEV1 (L) and (b) FEV1% of predicted (FEV1%) within the study groupsBack to article page